Navigation Links
Regenerative medicine: Clinical trials launched for the treatment of delayed union fractures
Date:1/9/2013

The clinical trials aim to repair bones using adult stem cells combined with biomaterials. It will be conducted in France in the Crteil University Hospital Centre and the Regional University Hospital Centre in Tours, in collaboration with the French Blood Establishment.

The REBORNE project began three years ago and its originality lies in using mesenchymal stem cells (MSC), found in bone marrow, to help heal fractures. Adult stem cells are amplified in culture, then are associated with biomaterial before being implanted on the fracture. Promising pre-clinical trials have now paved the way for the launch of these new clinical trials.

Following trauma (fall or road accident), there is a high incidence of delayed union or non-union in tibia, femur or humerus bones requiring a surgical apposition of an autologous bone graft (patient's own bone). However, the bone graft available is limited and complications are often observed at the second surgical site. The partners of the European project REBORNE propose an alternative treatment using autologous mesenchymal stem cells associated with a synthetic bone substitute. Thanks to a bone marrow aspiration under local anaesthesia, the mesenchymal stem cells are isolated and amplified in culture for 21 days. During the surgical intervention stem cells are associated with biphasic calcium phosphate ceramic granules and implanted at the site of the fracture. In this way, the biomaterial is used as "scaffolding" and encourages stem cell proliferation. The stem cells are then differentiated into bone cells and regenerate the bone tissue around the fracture. The French Medicinal Agency ANSM gave its green light on 3 January 2013 so that these Inserm-sponsored trials can now begin in France, with seven patients receiving treatment in the Crteil University Hospital Centre and the Regional University Hospital Centre in Tours. Ultimately, thirty patients will be included in France, Spain, Germany and Italy to be part of this multi-centre European study.

"The objective of this trial is to show that biomaterials and stem cells are safe and are at least equivalent to standard treatments, without their disadvantages. This surgery is less invasive and preserves the patients' bone stock. For these reasons, it is preferable to bone grafts in terms of triggering bone healing" explains Pierre Layrolle, director of Research, Inserm and coordinator of REBORNE.


'/>"/>

Contact: Pierre LAYROLLE
pierre.layrolle@inserm.fr
33-027-264-1143
INSERM (Institut national de la sant et de la recherche mdicale)
Source:Eurekalert

Related medicine news :

1. Dr. Farshchian: Plica of the knee is now being treated with regenerative medicine at he center for regenerative medicine.
2. New company applies regenerative medicine to corneal transplantation
3. Dr. Farshchian: Advanced Osteoarthritis of the Knee is Now being Treated with Regenerative Medicine at The Center for Regenerative Medicine
4. Dr. Farshchian : The knee joint is now being treated with regenerative medicine at he center for regenerative medicine
5. Dr. Farshchian: Chronic Exertional Compartment Syndrome Now Treated at the Center for Regenerative Medicine
6. Dr. Farshchian: The Center for regenerative medicine introduces Genorthix system
7. Dr. Farshchian: Tibialis Posterior Dysfunction is Now Being Treated at The Center for Regenerative Medicine in Miami
8. Dr. Farshchian: Rotator Cuff Injuries are being Treated Now Using Cell Therapy at the Center for Regenerative Medicine
9. Dr. Farshchian: Trochanter Bursitis is Now Treated at the Center for Regenerative Medicine
10. Dr. Farshchian: New treatment on Muscle Atrophy, now available at the Center for Regenerative Medicine
11. Dr. Farshchian: Muscular Contusions are Now Being Treated Successfully at The Center for Regenerative Medicine in Miami
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... ... As part of their 2015 end of year funding strategy, Colleen’s ... gifted $10,000 to University of Chicago to support ovarian cancer research being conducted by ... honored to support a promising young investigator from Dr. Lengyel’s lab at the University ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... the World Molecular Imaging Congress (WMIC), will be held in New York City, ... is “Imaging Biology…Improving Therapy.” The congress will highlight and emphasize how imaging reveals ...
(Date:2/10/2016)... ... 2016 , ... Early this week, Team Iconic at J. Walter Thompson and ... the first global confectionery brand sourced from 100% sustainable cocoa. , The Nestlé Cocoa ... product, through activities that focus on better farming, better lives and better cocoa. In ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... offering education, research and medical media, has launched Contagion® , a ... diseases. , As the all-inclusive resource for infectious disease information, Contagion features ...
(Date:2/10/2016)... ... February 10, 2016 , ... MetLoop CEO ... new 2.0 version at the International Roofing Expo in Orlando, Florida on February ... world's most advanced weather technology in the hands of consumers, roofing contractors, manufacturers ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... North America , ... The global market is expected to reach USD 20,190.1 Million by ... of 10.2%. --> North America , ... MarketsandMarkets, The global market is expected to reach USD 20,190.1 Million ... CAGR of 10.2%. --> According to a new market ...
(Date:2/11/2016)... , February 11, 2016 ... Market Report 2016 research report provides information on ... development status with crucial statistical data and information ... http://www.deepresearchreports.com/142870.html . --> Complete report on ... companies and supported with 296 tables and figures ...
(Date:2/10/2016)... , Feb. 11, 2016  QT Vascular Ltd., together ... and together with its subsidiaries, the "Group"), is ... litigation with AngioScore, Inc. ("ÄngioScore") (now owned by ... the United States Court ... Circuit") reversed an earlier district court order (the ...
Breaking Medicine Technology: